European Journal of Heart Failure

Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies
pp. 229-233(5)
Author: Swedberg K.

Angiotensin II antagonists are superior to ACE inhibitors; David vs. Goliath
pp. 235-236(2)
Author: Dickstein K.

'ACE inhibitors are better than AT₁ receptor blockers (ARBs)' - controversies in heart failure
pp. 237-240(4)
Authors: White H.L.; Hall A.S.

The role of cardiovascular magnetic resonance in heart failure
pp. 241-252(12)
Authors: Rajappan K.; Bellenger N.G.; Anderson L.; Pennell D.J.

Angiotensin converting enzyme (ACE) gene expression in the human left ventricle: effect of ACE gene insertion/deletion polymorphism and left ventricular function
pp. 253-256(4)
Authors: Davis G.K.; Millner R.W.J.; Roberts D.H.

Pentoxifylline-augmented antiproliferative effects of adrenomedullin on vascular smooth muscle cells
pp. 257-260(4)
Authors: Dunzendorfer S.; Meierhofer C.; Xu Q.; Wiedermann C.J.

Catecholamine levels in heart failure due to dilated cardiomyopathy and their relationship to the severity of heart failure
pp. 261-263(3)
Authors: Agarwal A.K.; Venugopalan P.; Woodhouse C.; de Bono D.

QT interval lengthening in cardiac disease relates more to left ventricular systolic dysfunction than to autonomic function
pp. 265-271(7)
Author: Davey P.

Comparison of different methods of functional evaluation in patients with chronic heart failure
pp. 273-280(8)
Authors: Rostagno C.; Galanti G.; Comeglio M.; Boddi V.; Olivo G.; Gastone Neri Serneri G.

Does in-patient ECG monitoring have an impact on medical care in chronic heart failure patients?
pp. 281-285(5)
Authors: Opasich C.; Capomolla S.; Riccardi P.G.; Febo O.; Forni G.; Cobelli F.; Tavazzi L.

Experience of commencing Carvedilol in elderly patients with heart failure in a routine outpatient clinic
pp. 287-289(3)
Author: Owen A.

Health care costs of heart failure: results from a randomised study of patient education
pp. 291-297(7)
Authors: Linne A.B.; Liedholm H.; Jendteg S.; Israelsson B.

First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril
pp. 299-304(6)
Authors: Vtovec J.; Spinar J.

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure
pp. 305-313(9)
Authors: Paterna S.; Di Pasquale P.; Parrinello G.; Amato P.; Cardinale A.; Follone G.; Giubilato A.; Licata G.

Screening, endpoint classification, and safety monitoring in the Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
pp. 315-324(10)
Author: Fagerberg B.

Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction
pp. 325-332(8)
Author: Dargie H.J.

Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials
pp. 333-340(8)
Authors: Houghton T.; Freemantle N.; Cleland J.G.F.

The management of heart failure in Spain
pp. 341-344(4)
Authors: Masia R.; Sala J.; Marrugat J.; Roure J.; Cosn-Aguilar J.

How patients with heart failure are managed in Georgia
pp. 345-346(2)
Authors: Kobulia B.; Paposhvili K.; Chapichadze Z.; Jashi I.